Piramal Enterprises has raised Rs 215 crore through Secured, Rated, Listed, Redeemable Principal Protected, Market Linked Non-Convertible Debentures (NCDs) and allotted 2,150 NCDs having a face value of Rs 10,00,000 each on private placement basis. These Debentures are proposed to be listed on the Debt Segment and Capital Market Segment of National Stock Exchange of India (NSE) and BSE respectively, and NSE being the designated Stock Exchange. The meeting of Administrative Committee of the Board of Directors at its meeting held on September 20, 2022 approved the same.
Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.
